Related Experiment Videos

[Antithrombotic therapy in patients with prosthetic heart valves]

G E Gendlin, O A Tronina, G I Storozhakov

    Kardiologiia
    |December 2, 2010
    PubMed

    Insights

    Anticoagulant therapy is crucial for patients with prosthetic heart valves. This review outlines antithrombotic strategies for different valve types and clinical scenarios, referencing European and American guidelines.

    Area of Science:

    • Cardiology
    • Vascular Medicine
    • Pharmacology

    Background:

    • Anticoagulant therapy is essential for managing patients with prosthetic heart valves.
    • Optimal antithrombotic strategies are critical to prevent thromboembolic complications.
    • Current national guidelines for anticoagulation in this patient group are lacking.

    Purpose of the Study:

    • To review specific challenges in antithrombotic therapy for diverse prosthetic heart valve types.
    • To outline management tactics for various clinical situations involving prosthetic heart valves.
    • To provide evidence-based recommendations in the absence of national guidelines.

    Main Methods:

    • Literature review of recent European and American guidelines.
    • Analysis of antithrombotic therapy principles for prosthetic heart valves.
    • Synthesis of clinical data and expert opinion.

    Main Results:

    • Discussion of individualized anticoagulation based on valve type (mechanical, bioprosthetic) and patient factors.
    • Consideration of specific clinical scenarios such as atrial fibrillation, surgery, and bleeding risk.
    • Proposed management schemes aligned with international standards.

    Conclusions:

    • Effective anticoagulation management is vital for prosthetic heart valve recipients.
    • Adherence to established international guidelines is recommended in the absence of national protocols.
    • Tailored antithrombotic strategies improve patient outcomes and reduce complications.

    Related Concept Videos

    Venous Thrombosis III: Interprofessional Care01:29

    Venous Thrombosis III: Interprofessional Care

    Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
    Rheumatic Heart Disease III: Medical Management01:21

    Rheumatic Heart Disease III: Medical Management

    Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
    Mitral Stenosis III: Medical Management01:26

    Mitral Stenosis III: Medical Management

    Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    Venous Thrombosis IV: Nursing Management01:30

    Venous Thrombosis IV: Nursing Management

    Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...